Stocks making the biggest moves after hours: Ulta, Gap, Dell and more

Finance

Bloomberg | Bloomberg | Getty Images

Check out the companies making headlines after the bell

Ulta Beauty — Shares surged more than 6% after hours as the beauty retailer’s quarterly report beat Wall Street estimates on the top and bottom lines. Ulta Beauty posted adjusted first-quarter earnings of $6.30 per share on revenue of $2.346 billion. Analysts had expected a profit of $4.46 per share on revenue of $2.122 billion, according to Refinitiv. The company also issued better-than-expected forward guidance for the full year.

Gap — The retail stock sank about 13% in extended trading after Gap slashed its profit outlook for the year. Old Navy weighed on results as Gap management said the segment’s lower-income customers are feeling the pressure of inflation.

Costco — Shares fell more than 2% post market despite the wholesale retailer posting better-than-expected quarterly sales. Costco saw revenue of $52.596 billion versus the Refinitiv consensus estimate of $51.707 billion.

Dell — The laptop maker rose more than 5% in extended trading after Dell reported a revenue beat in the first quarter. Dell posted $26.12 billion in revenue versus the Refinitiv consensus estimate of $25.043 billion

Marvell Technology — Shares ticked up 2.2% after hours as the semiconductor company reported strong quarterly results. Marvell reported adjusted first-quarter earnings of $50.52 per share on revenue of $1.447 billion. Analysts had expected a profit of $0.51 per share on revenue of $1.427 billion, according to Refinitv.

American Eagle — The stock dropped more than 10% after the retailer posted weaker-than-expected quarterly revenue. American Eagle reported $1.055 billion in revenue versus the Refinitiv consensus estimate of $1.142 billion.

Articles You May Like

Surprising Facts To Know About IRA Conversions
Some students are still struggling to access college aid amid ongoing FAFSA ‘disaster’
World’s busiest airports show surge in international travel. Here are the rankings
Here’s Why You Should Continue Investing After Retirement
Most doses of Eli Lilly’s Zepbound, Mounjaro in short supply through June, FDA says 

Leave a Reply

Your email address will not be published. Required fields are marked *